Literature DB >> 1379820

Interaction of charybdotoxin with permeant ions inside the pore of a K+ channel.

C S Park1, C Miller.   

Abstract

Charybdotoxin (CTX) blocks high conductance Ca(2+)-activated K+ channels by binding to a receptor site in the externally facing "mouth." Toxin bound to the channel can be destabilized from its site by K+ entering the channel from the opposite, internal, solution. By analyzing point mutants of CTX expressed in E. coli, assayed with single Ca(2+)-activated K+ channels reconstituted into planar lipid bilayers, we show that a single positively charged residue of the peptide, Lys-27, wholly mediates this interaction of K+ with CTX. If position 27 carries a positively charged residue, internal K+ accelerates the dissociation rate of CTX in a voltage-dependent manner; however, if a neutral Asn or Gln is substituted at this position, the dissociation rate is completely insensitive to either internal K+ or applied voltage. Position 27 is unique in this respect; charge-neutral substitutions made at other positions fail to eliminate the K+ destabilization phenomenon. The results argue that CTX bound to the channel positions Lys-27 physically close to a K(+)-specific binding site on the external end of the conduction pathway and that a K+ ion occupying this site destabilizes CTX via direct electrostatic repulsion with the epsilon-amino group of Lys-27.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379820     DOI: 10.1016/0896-6273(92)90169-e

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  60 in total

1.  Mechanisms of maurotoxin action on Shaker potassium channels.

Authors:  V Avdonin; B Nolan; J M Sabatier; M De Waard; T Hoshi
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

2.  Interaction of SNX482 with domains III and IV inhibits activation gating of alpha(1E) (Ca(V)2.3) calcium channels.

Authors:  E Bourinet; S C Stotz; R L Spaetgens; G Dayanithi; J Lemos; J Nargeot; G W Zamponi
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

3.  Inhibition of single Shaker K channels by kappa-conotoxin-PVIIA.

Authors:  David Naranjo
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

4.  BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.

Authors:  Mei Zhang; Yuliya V Korolkova; Jie Liu; Min Jiang; Eugene V Grishin; Gea-Ny Tseng
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

5.  Modeling the structure of agitoxin in complex with the Shaker K+ channel: a computational approach based on experimental distance restraints extracted from thermodynamic mutant cycles.

Authors:  Mats A L Eriksson; Benoît Roux
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

6.  Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel.

Authors:  Kunqian Yu; Wei Fu; Hong Liu; Xiaomin Luo; Kai Xian Chen; Jianping Ding; Jianhua Shen; Hualiang Jiang
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

7.  Permeation and block of the Kv1.2 channel examined using brownian and molecular dynamics.

Authors:  Dan Gordon; Shin-Ho Chung
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

8.  Modeling the binding of three toxins to the voltage-gated potassium channel (Kv1.3).

Authors:  Rong Chen; Anna Robinson; Dan Gordon; Shin-Ho Chung
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

9.  Binding modes of μ-conotoxin to the bacterial sodium channel (NaVAb).

Authors:  Rong Chen; Shin-Ho Chung
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

10.  Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.

Authors:  Zoltan Varga; Georgina Gurrola-Briones; Ferenc Papp; Ricardo C Rodríguez de la Vega; Gustavo Pedraza-Alva; Rajeev B Tajhya; Rezso Gaspar; Luis Cardenas; Yvonne Rosenstein; Christine Beeton; Lourival D Possani; Gyorgy Panyi
Journal:  Mol Pharmacol       Date:  2012-05-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.